Skip to main content
. 1999 Mar 16;96(6):3087–3091. doi: 10.1073/pnas.96.6.3087

Table 3.

Details of antibodies used

Antibody Target Dilution Source
HECD-1 E-cadherin neat supernatant ICRF
α-catenin α-catenin 1:500  Affinity (Nottingham, U.K.)
β-catenin β-catenin 1:1000 Affinity
γ-catenin γ-catenin 1:1000 Affinity
Ali-28 APC (N-terminal) 1:50   ICRF, ref. 20
PR1A3 CEA 1:1000 ICRF, ref. 21

APC, antigen-presenting cell; CEA, carcinoembryonic antigen; ICRF, Imperial Cancer Research Fund.